Results
Between 2009 and 2019, we identified a total of 91 patients with advanced cutaneous carcinoma, 11 patients with basal cell carcinomas were excluded, 3 were lost to follow-up and 3 others refused surgical treatment. The final group of 74 patients, all with laCSCC or reCSCC in the head and neck region, was designated as the study group and divided according to parotid metastases status into positive parotid metastasis group (PM) with 37 patients who was compared to the without parotid metastases (WPM) group with 37 patients.